Food Allergy News and Research

[Press Release] Kaléo Donates Thousands of AUVI-Q® (epinephrine injection, USP) and EVZIO® (naloxone HCl injection) Auto-injectors to Hurricane Harvey Relief Efforts RICHMOND, Va., Sept. 1, 2017 /PRNewswire/ -- Kaléo, a privately-held pharmaceutical company, today announced a donation of 20,000 AUVI-Q® (epinephrine injection, USP) Auto-injectors and 5,000 EVZIO® (naloxone HCl injection) Auto-injectors to medical aid organization Direct Relief in support of Hurricane Harvey relief efforts in...

Governor Andrew Cuomo has signed legislation sponsored by Assemblyman David Buchwald (D-Westchester) to allow school bus drivers and other contractors providing services to schools to administer epinephrine when a child suffers anaphylaxis shock.

Kids With Food Allergies is sharing this press release from Kaléo to bring you the latest research and news quickly. [Press Release] Kaléo Announces AUVI-Q ® (epinephrine injection, USP) Charitable Donation Program for All Public Elementary Schools in the United States -- More than 67,000 Schools Eligible for the “Q Your School TM ” Program -- Richmond, VA (August 7, 2017) Kaléo, a privately-held pharmaceutical company, today announced a new charitable product donation program, offering...

Kaléo, a privately-held pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review of its supplemental New Drug Application (sNDA) for AUVI-Q 0.1 mg, the first known epinephrine auto-injector specifically designed for the treatment of life-threatening allergic reactions in infants and small children weighing 16.5 to 33 pounds.

[PRESS RELEASE] Study shows parents, guardians and emergency responders failed to give epinephrine at home. ARLINGTON HEIGHTS, IL (July 12, 2017 – 12:01 am ET) – Anyone suffering a severe allergic reaction (anaphylaxis) should receive epinephrine as quickly as possible. A new study showed that even kids who were prescribed an epinephrine auto injector didn’t receive the life-saving medication when they needed it. The study in Annals of Allergy, Asthma and Immunology , the scientific...

Adamis Pharmaceuticals Corporation announced that the U.S. Food and Drug Administration (“FDA”) has approved Adamis’ EPINEPHRINE INJECTION, USP, 1:1000 (0.3 mg Pre-filled single dose syringe) (“PFS”) for the emergency treatment of allergic reactions (Type I) including anaphylaxis. The FDA has also approved the PFS trade name of Symjepi™.

[Press Release] Kmart® Pharmacy Lowers Cost of Generic Epinephrine Auto-injector Pens SOURCE Kmart $0 Copays Attainable for Commercially Insured Patients HOFFMAN ESTATES, Ill. , April 25, 2017 /PRNewswire/ -- In response to the massive increase in the cost of epinephrine auto-injector pens, Kmart Pharmacy lowered the cost of the generic version of Adrenaclick (epinephrine injection, USP auto-injector) as low as $0 for commercially insured patients* and $199.99 for cash paying patients per...

Kids With Food Allergies will recap some of the top research in food allergies every three months. Here is a look at studies reported between January and March. Read about teens and food allergy, peanut allergy, secondhand smoke and more.

Aimmune Therapeutics, Inc. (Nasdaq:AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, announced clinical data presented today at the 2017 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in Atlanta. The presentations included Phase 3 screening data and Phase 2 adherence data from Aimmune’s AR101 program. AR101 is Aimmune’s investigational biologic oral immunotherapy for desensitization of patients with peanut allergy.

Secondhand smoke exposure is a well-established risk factor for asthma, but it may also have surprising effects in the development of diseases outside of the respiratory system. In the first study of its kind, researchers in Sweden investigated the link between early life secondhand smoke exposure and pediatric food-related symptoms.

After the success of the yearlong double-blind, placebo controlled randomized Phase IIb trial for a peanut patch, known as Viaskin® Peanut, researchers continued the trial two more years in an open label extension to ascertain the effect of long-term treatment.

The American Academy of Pediatrics (AAP) reaffirmed epinephrine as the first choice to treat severe allergic reactions. And to make certain parents, caregivers and others are ready to treat anaphylaxis, the AAP released its own version of a food allergy action plan . 1 Download PDF The recommendations were released in the February 13 edition of the journal Pediatrics . 2 The report stresses that it is better to use epinephrine early, even if parents are not 100% sure that the symptoms are...